MedCity News November 30, 2023
Stephanie Baum

Alpha Sophia Founder and CEO Paul-Lukas Hoffschmidt explains how the company’s software diverges from competitors in healthcare commercial intelligence, by focusing on smaller medtech innovators.

Alpha Sophia Founder and CEO Paul-Lukas Hoffschmidt explains how the company’s software diverges from competitors in healthcare commercial intelligence, with a focus on smaller innovators.

Why did you start this company?

There are approximately 15,000 startups and small to medium-sized businesses (SMBs) in the medtech and digital health space spearheading some of the most important innovations in healthcare today. However, these innovators lack the boundless resources of large healthcare players who can place a sales rep in every county. They are often forced to make critical decisions regarding the commercialization of their products with limited...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Interview / Q&A, Medical Devices, Trends
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article